CHPA opposes Maine bill
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association opposes a bill approved by Maine's House of Representatives that would require drug manufacturers to fund a system for disposing of unwanted Rx and OTC drugs. A CHPA spokeswoman said the trade group instead supports consumers using "more effective means of ensuring safe medicine disposal which not only protect the environment, but also prevent illegitimate access to drugs, decrease potential abuse and limit accidental poisonings." CHPA backs the SMARxT Disposal campaign, which educates consumers on proper disposal of unwanted medicines and which the American Pharmacists Association supports. The bill received a 91-51 vote March 17 and moves next to the Senate
You may also be interested in...
Maine drug disposal bill dies
The Maine Senate indefinitely postpones legislation passed by the House that would have impelled manufacturers to contribute to an "Unused Pharmaceutical Disposal Program Fund." The Senate placed LD 821 in legislative files March 26, effectively killing it. The Consumer Healthcare Products Association opposed the bill and favors consumer education on safe drug disposal (1"The Tan Sheet" March 22, 2010, In Brief)
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip